Charles Alessi is the Chief Clinical Officer for HIMSS International. HIMSS is a global voice, advisor and thought leader of health transformation through health information and technology with a unique breadth and depth of expertise and capabilities to improve the quality, safety, and efficiency of health, healthcare and care outcomes.
As Chief Clinical Officer for HIMSS International, Alessi leads relationship-building efforts among HIMSS’s various international clinician-focused communities; furthering HIMSS's position as a thought leader in the health industry and supporting both the vision and understanding of information and technology’s roles in the advancement of health and care.
Before joining HIMSS in 2018, Alessi has acted in numerous external positions for governments and executive agencies on a national and international level. Alessi brings more than 25 years of experience in global healthcare policy and clinical practice to HIMSS. Most recently, he chaired the National Association of Primary Care (NAPC), has served as an adjunct research professor for Clinical Neurosciences at the Schulich School of Medicine for University of Western Ontario Canada, and as executive director of the Global International Care Delivery Alliance.
Alessi is also the senior advisor for Public Health England, leading national policy implementation, productive healthy aging and is currently contributing to the global World Health Organization guidelines for dementia risk reduction. Alessi has also contributed his expertise to multiple international publications such as the British Journal of General Practice, addressing topics such as health and social care contract and health policy. He has lectured and led keynote addresses for h
The Roundtable Discussion will focus on digital health in different healthcare systems - its role, implementation and how it will transform healthcare in the future.
- Comparison between different countries (status quo and future plans)
- How do different healthcare systems transform digital health?
- What are the strategies?
- Responsible and secure sharing of genomic and health data is key to both accelerating research and improving human health. This session will focus on empowering personalised health through data sharing. From tools and standards required for genomic and phenotypic data, federated networks for secure and responsible sharing to using human genetics to make new medicines.
Asklepios is the second largest private hospital chain in Germany serving 3.2 million patients annually in over 150 health institutions. Over the last years several digital solutions have been successfully introduced at Asklepios including EHR, digital outpatient management, and telemedicine applications. This journey was companied by numerous communication measures and change procedures which will be critically reviewed. In addition, the potential of digital care to reduce costs, increase access, and improve outcomes especially for a hospital corporation will be addressed.